These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8785225)

  • 1. S. aureus nasal carriage: importance and approaches.
    Piraino B
    Perit Dial Int; 1995; 15(8):301-2. PubMed ID: 8785225
    [No Abstract]   [Full Text] [Related]  

  • 2. Is it possible to decrease the rate of Staphylococcus aureus peritonitis?
    Piraino B
    Perit Dial Int; 1996; 16(5):446-7. PubMed ID: 8914174
    [No Abstract]   [Full Text] [Related]  

  • 3. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin.
    Bernardini J; Piraino B; Holley J; Johnston JR; Lutes R
    Am J Kidney Dis; 1996 May; 27(5):695-700. PubMed ID: 8629630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and economic effects of mupirocin calcium on preventing Staphylococcus aureus infection in hemodialysis patients: a decision analysis.
    Bloom BS; Fendrick AM; Chernew ME; Patel P
    Am J Kidney Dis; 1996 May; 27(5):687-94. PubMed ID: 8629629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of Staphylococcus aureus nasal carriage and infection in dialysis patients.
    Herwaldt LA
    J Hosp Infect; 1998 Sep; 40 Suppl B():S13-23. PubMed ID: 9777529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eradication of nasal carriage of Staphylococcus aureus--is it cost-effective?
    Davey P
    J Hosp Infect; 1998 Sep; 40 Suppl B():S31-7. PubMed ID: 9777531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis. Mupirocin Study Group.
    J Am Soc Nephrol; 1996 Nov; 7(11):2403-8. PubMed ID: 8959632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Staphylococcus aureus decolonization.
    Chen SF
    Pediatr Infect Dis J; 2005 Jan; 24(1):79-80. PubMed ID: 15665714
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of preventing Staphylococcus aureus carriage on rates of peritoneal catheter-related staphylococcal infections. Literature synthesis.
    Ritzau J; Hoffman RM; Tzamaloukas AH
    Perit Dial Int; 2001; 21(5):471-9. PubMed ID: 11757831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome and clinical implications of a surveillance and treatment program for Staphylococcus aureus nasal carriage in peritoneal dialysis patients.
    Crabtree JH; Hadnott LL; Burchette RJ; Siddiqi RA
    Adv Perit Dial; 2000; 16():271-5. PubMed ID: 11045309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Pulse" nasal mupirocin maintenance regimen in patients undergoing continuous ambulatory peritoneal dialysis.
    Mylotte JM; Kahler L; Jackson E
    Infect Control Hosp Epidemiol; 1999 Nov; 20(11):741-5. PubMed ID: 10580624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of nasal carriage of Staphylococcus aureus and the incidence of postoperative wound infection.
    Wenzel RP; Perl TM
    J Hosp Infect; 1995 Sep; 31(1):13-24. PubMed ID: 7499817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of staphylococcal peritonitis in CAPD patients combining ablution and mupirocin.
    Al-Hwiesh AK; Abdul Rahman IS
    Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):737-45. PubMed ID: 18711288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staphylococcus aureus nasal carriage in children receiving long-term peritoneal dialysis.
    Kingwatanakul P; Warady BA
    Adv Perit Dial; 1997; 13():281-4. PubMed ID: 9360700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staphylococcus aureus infections in haemodialysis patients: pathophysiology and use of nasal mupirocin for prevention.
    Boelaert JR; Van Landuyt HW; De Baere YA; Deruyter MM; Daneels RF; Schurgers ML; Matthys EG; Gordts BZ
    J Chemother; 1995 Jul; 7 Suppl 3():49-53. PubMed ID: 8609538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of mupirocin treatment on nasal, pharyngeal, and perineal carriage of Staphylococcus aureus in healthy adults.
    Wertheim HF; Verveer J; Boelens HA; van Belkum A; Verbrugh HA; Vos MC
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1465-7. PubMed ID: 15793127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between nasal methicillin-resistant Staphylococcus aureus carriage and infection in liver transplant recipients.
    Patel R
    Liver Transpl; 2001 Aug; 7(8):752-3. PubMed ID: 11780649
    [No Abstract]   [Full Text] [Related]  

  • 18. Mupirocin prophylaxis against nosocomial Staphylococcus aureus infections in nonsurgical patients: a randomized study.
    Wertheim HF; Vos MC; Ott A; Voss A; Kluytmans JA; Vandenbroucke-Grauls CM; Meester MH; van Keulen PH; Verbrugh HA
    Ann Intern Med; 2004 Mar; 140(6):419-25. PubMed ID: 15023707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staphylococcus aureus nasal carriage: role in continuous ambulatory peritoneal dialysis-associated infections.
    Herwaldt LA
    Perit Dial Int; 1993; 13 Suppl 2():S301-5. PubMed ID: 8399593
    [No Abstract]   [Full Text] [Related]  

  • 20. Prophylactic intranasal mupirocin ointment in the treatment of peritonitis in continuous ambulatory peritoneal dialysis patients.
    Sit D; Kadiroglu AK; Kayabasi H; Yilmaz ME
    Adv Ther; 2007; 24(2):387-93. PubMed ID: 17565930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.